These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12451314)

  • 1. Contractile effect of anaphylatoxin C5a and of a mimetic peptide on the human umbilical artery: further evidence for leukocyte-dependent vasomotion.
    Fortin JP; Bouthillier J; St-Pierre SA; Marceau F
    J Cardiovasc Pharmacol; 2002 Dec; 40(6):815-21. PubMed ID: 12451314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contractile effect of the chemotactic factors f-Met-Leu-Phe and C5a on the human isolated umbilical artery. Role of cyclooxygenase products and tissue macrophages.
    Marceau F; deBlois D; Laplante C; Petitclerc E; Pelletier G; Grose JH; Hugli TE
    Circ Res; 1990 Nov; 67(5):1059-70. PubMed ID: 1699682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation.
    Vogen SM; Paczkowski NJ; Kirnarsky L; Short A; Whitmore JB; Sherman SA; Taylor SM; Sanderson SD
    Int Immunopharmacol; 2001 Nov; 1(12):2151-62. PubMed ID: 11710544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
    Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD
    J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of Lys68 in decepeptide agonists of C5a on C5a receptor binding, activation and selectivity.
    Vogen SM; Finch AM; Wadi SK; Thatcher J; Monk PN; Taylor SM; Sanderson SD
    J Pept Res; 1999 Jan; 53(1):8-17. PubMed ID: 10195437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and preliminary pharmacological characterization of the anaphylatoxin C5a receptor in the rabbit.
    Bachvarov DR; Houle S; Bachvarova M; Bouthillier J; St-Pierre SA; Fukuoka Y; Ember JA; Marceau F
    Br J Pharmacol; 1999 Sep; 128(2):321-6. PubMed ID: 10510441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation by anaphylatoxin C5a of glycogen phosphorylase in rat hepatocytes via prostanoid release from hepatic stellate cells but not sinusoidal endothelial cells.
    Schieferdecker HL; Pestel S; Rothermel E; Püschel GP; Götze O; Jungermann K
    FEBS Lett; 1998 Sep; 434(3):245-50. PubMed ID: 9742932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboxane is produced in response to intracoronary infusions of complement C5a in pigs. Cyclooxygenase blockade does not reduce the myocardial ischemia and leukocyte accumulation.
    Ito BR; Roth DM; Chenoweth DE; Lefer AM; Engler RL
    Circ Res; 1989 Nov; 65(5):1220-32. PubMed ID: 2509096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic leukocyte infiltration of the rabbit aorta confers a vasomotor effect to chemotactic peptides through cyclooxygenase-derived metabolites.
    Petitclerc E; Levesque L; Grose JH; Poubelle PE; Marceau F
    J Immunol; 1996 May; 156(9):3426-34. PubMed ID: 8617969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response-selective C5a agonists: differential effects on neutropenia and hypotension in the rat.
    Short AJ; Paczkowski NJ; Vogen SM; Sanderson SD; Taylor SM
    Br J Pharmacol; 1999 Oct; 128(3):511-4. PubMed ID: 10516626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells.
    Farkas I; Baranyi L; Liposits ZS; Yamamoto T; Okada H
    Neuroscience; 1998 Oct; 86(3):903-11. PubMed ID: 9692726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation.
    McCoy R; Haviland DL; Molmenti EP; Ziambaras T; Wetsel RA; Perlmutter DH
    J Exp Med; 1995 Jul; 182(1):207-17. PubMed ID: 7540650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of functional anaphylatoxin C5a receptors on hepatocytes by in vivo treatment of rats with IL-6.
    Schieferdecker HL; Schlaf G; Koleva M; Götze O; Jungermann K
    J Immunol; 2000 May; 164(10):5453-8. PubMed ID: 10799912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Xenopus oocytes the human C3a and C5a receptors elicit a promiscuous response to the anaphylatoxins.
    Ames RS; Nuthulaganti P; Kumar C
    FEBS Lett; 1996 Oct; 395(2-3):157-9. PubMed ID: 8898085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
    J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
    Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
    J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of leukocytes with complement C5a is associated with prostanoid-dependent constriction of large arteries in atherosclerotic monkeys in vivo.
    Mügge A; Heistad DD; Densen P; Piegors DJ; Armstrong ML; Padgett RC; Lopez JA
    Atherosclerosis; 1992 Aug; 95(2-3):211-22. PubMed ID: 1418094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses of isolated pulmonary arteries to the C5a anaphylatoxin.
    Crowell RE; Van Epps DE; Reed WP
    Am J Physiol; 1990 Nov; 259(5 Pt 2):H1325-9. PubMed ID: 2122743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
    Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
    FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoconstriction in response to activated leukocytes: implications for vasospasm.
    Mügge A; Lopez JA; Heistad DD; Lichtlen PR
    Eur Heart J; 1993 Nov; 14 Suppl I():87-92. PubMed ID: 8293785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.